Igs7tm134.1(tetO-COP4*H134R/EYFP)Hze
Targeted Allele Detail
|
Symbol: |
Igs7tm134.1(tetO-COP4*H134R/EYFP)Hze |
Name: |
intergenic site 7; targeted mutation 134.1, Hongkui Zeng |
MGI ID: |
MGI:6151056 |
Synonyms: |
Ai134, Ai134(TITL-ChR2-YFP) |
Gene: |
Igs7 Location: unknown Genetic Position: Chr9, Syntenic
|
Alliance: |
Igs7tm134.1(tetO-COP4*H134R/EYFP)Hze page
|
|
|
Allele Type: |
|
Targeted (Conditional ready, Inducible, Reporter) |
Inducer: |
|
doxycycline/tetracycline |
Mutation: |
|
Insertion
|
|
|
Mutation details: The vector is designed with (from 5' to 3') an FRT3 site, two copies of chicken beta-globin HS4 insulator element (to reduce reporter gene expression in absence of transactivators), a Tet response element/promoter, a floxed-STOP cassette (stop codons in all three reading frames linked to synthetic pA-hGHpA-PGKpA), the ChR2(H134R)-EYFP fusion sequence, a WPRE (to enhance mRNA stability), a BGH polyA, two copies of chicken beta-globin HS4 insulator element, an AttB site, a PGK-5'hygro cassette, an RNA splice donor and a FRT5 site.
PhiC31-mediated recombination removed the AttB/AttP-flanked sequence and replaced it with the recombined AttB/AttP site (AttL).
(J:260362)
|
|
|
|
Original: |
J:260362 Daigle TL, et al., A suite of transgenic driver and reporter mouse lines with enhanced brain cell type targeting and functionality. Cell. 2018 Jul 12;174(2):465-480.e22 |
All: |
1 reference(s) |
|